Literature DB >> 12491218

A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.

Pierre Tattevin, Mathieu Revest, Mathieu Dupont, Cédric Arvieux, Christian Michelet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12491218     DOI： 10.1086/345532

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Experience with rifabutin replacing rifampin in the treatment of tuberculosis.

Authors:  D J Horne; C Spitters; M Narita
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

2.  Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients.

Authors:  Rannakoe J Lehloenya; Sipho Dlamini; Rudzani Muloiwa; Betty Kakande; Mzudumile R Ngwanya; Gail Todd; Keertan Dheda
Journal:  Open Forum Infect Dis       Date:  2016-06-20       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.